Yes, amoxicillin can treat acute bacterial rhinosinusitis, but most sinus infections do not need it. Roughly 90 to 98 percent of acute cases are viral and resolve without antibiotics. When bacteria are responsible, amoxicillin remains a reasonable first-line option for most adults without recent antibiotic exposure or complicating factors. The harder question is not whether the drug works, but when it is genuinely warranted, because unnecessary use drives resistance and side effects without shortening illness.
What Amoxicillin Does Inside the Sinus Cavity
Amoxicillin is an aminopenicillin that blocks bacterial cell-wall construction. It binds penicillin-binding proteins, the enzymes bacteria use to cross-link peptidoglycan strands. Without that cross-linking, the wall weakens and the cell ruptures under its own internal pressure.
The drug works best against actively dividing bacteria. That matters in sinus infections because bacteria trapped in thickened mucus divide slowly. Amoxicillin also achieves good tissue penetration in sinus mucosa and secretions, which is why it has historically been a first-line choice for susceptible organisms.
Acute bacterial rhinosinusitis most often involves Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis. Amoxicillin covers all three reasonably well, though many H. influenzae and nearly all M. catarrhalis strains produce beta-lactamases that degrade plain amoxicillin. That single fact explains why high-dose regimens and beta-lactamase-stable alternatives exist.
Bacteria also form biofilms on sinus mucosa, and biofilm-embedded cells tolerate antibiotics 10 to 1,000 times better than free-floating cells. In plain terms, the drug reaches the sinus, but the physical environment of a blocked, inflamed cavity makes killing harder than in a test tube.
Why Most Sinus Infections Do Not Need It
The defining feature of viral and bacterial sinusitis is inflammation of the nasal lining, not necessarily infection of the sinus cavity. Viruses trigger the same swelling, mucus production, and ostial blockage that bacteria later exploit. Antibiotics do nothing to a virus, so the drug adds risk without benefit.
Time course distinguishes the two. Viral illness peaks in 3 to 5 days and improves. Bacterial superinfection typically presents with symptoms lasting 10 days or more without improvement, or with severe onset: fever of at least 102°F (39°C), facial pain, and purulent discharge for 3 to 4 consecutive days.
A third pattern is the double worsening: symptoms improve, then flare again around day 5 to 6. This "double sickening" pattern has reasonable specificity for bacterial disease and appears in major society guidance.
Consider the arithmetic. If 95 percent of cases are viral and antibiotics help only the bacterial minority, treating everyone exposes 100 patients to drug side effects so that perhaps 3 to 5 benefit. Diarrhea occurs in roughly 5 to 10 percent of amoxicillin courses, and rash in a smaller share.
Bacterial Criteria and the 10-Day Rule
Two clinical frameworks anchor diagnosis. The Infectious Diseases Society of America defines acute bacterial rhinosinusitis by symptoms lasting 10 days or longer without improvement, severe symptoms with fever of at least 102°F plus purulent discharge or facial pain for 3 to 4 days, or the double-worsening pattern.
The American Academy of Otolaryngology–Head and Neck Surgery uses similar thresholds but emphasizes that diagnosis remains clinical. Neither body requires imaging for uncomplicated cases. Routine sinus X-rays and CT scans add cost and radiation without changing first-line decisions.
When antibiotics are indicated, amoxicillin is a reasonable first-line choice for adults without recent antibiotic use. Guidance from major societies suggests amoxicillin-clavulanate when there has been antibiotic exposure within the past 30 days, when local resistance rates to plain amoxicillin exceed roughly 20 percent, or when the patient has failed initial therapy.
That 20 percent figure is a resistance threshold, not a patient threshold. It reflects population-level H. influenzae beta-lactamase prevalence. Your personal decision changes only if you fall into a risk category, not because a regional statistic crossed a line.
A professional caveat many thin explainers miss: penicillin allergy labels are wrong in about 90 percent of people who carry them, according to allergy society estimates. Most labeled patients can safely take amoxicillin after proper evaluation, which widens the cheap, narrow-spectrum option considerably.
When Symptoms Do Not Fit the Script
Several conditions mimic bacterial sinusitis and will not respond to amoxicillin. A deviated septum or nasal polyp causes obstruction and congestion that antibiotics cannot fix. Allergic rhinitis produces clear discharge and sneezing that point away from infection.
Dental origin matters more than most people realize. Maxillary sinusitis can arise from an infected upper molar whose root sits near the sinus floor. In that case, the tooth needs treatment and antibiotics alone will recur.
Fungal sinusitis, odontogenic disease, and medication-related rhinitis each require different management. So does chronic rhinosinusitis, defined by 12 or more weeks of symptoms. Chronic disease is primarily inflammatory, and antibiotics play a limited, targeted role rather than a routine one.
Red-flag symptoms demand urgent evaluation rather than an outpatient prescription:
Swelling or redness around the eye, or vision changes, suggesting orbital spread. Severe headache with fever and neck stiffness. Confusion, facial numbness, or one-sided weakness. Symptoms that worsen rapidly despite 48 to 72 hours of appropriate antibiotics. Immunocompromise or recent sinus surgery.
These features can signal complications such as orbital cellulitis or intracranial extension, which require imaging and specialist care, not a refill.
The Misconceptions That Drive Overuse
The most persistent myth is that green or yellow mucus proves bacterial infection. Color comes from neutrophil enzymes and dead cells, and viral illness produces the same hue. Studies show discharge color does not reliably separate viral from bacterial causes.
A second misconception treats antibiotics as fast relief. Even in confirmed bacterial cases, symptom improvement typically lags 48 to 72 hours behind the first dose. Patients who expect same-day change often conclude the drug failed when the clock simply had not run.
A counterintuitive detail: intranasal corticosteroid sprays show modest benefit for acute sinusitis in some trials, largely by reducing mucosal swelling that blocks sinus drainage. Saline irrigation has weaker evidence but low risk. Neither is a substitute for antibiotics in a true bacterial case, but both address the mechanical problem antibiotics cannot.
A third misconception is that finishing every course prevents resistance, regardless of whether infection was bacterial. Resistance selection is driven by exposure, and unnecessary courses increase it. The modern principle is narrow, targeted, and only when indicated.
Finally, symptom duration after treatment matters. Post-viral cough and congestion can persist 2 to 4 weeks even after the bacterial component clears. Persistent symptoms at day 14 do not automatically mean treatment failure.
First-Line Therapy vs. Alternatives
| Option | Role | Key considerations |
|---|---|---|
| Amoxicillin | First-line for uncomplicated cases without recent antibiotics | Narrow spectrum, low cost, good sinus penetration |
| Amoxicillin-clavulanate | First-line with recent antibiotic use or high local resistance | Broader coverage, more GI upset |
| Doxycycline | Alternative for penicillin allergy | Useful in adults, not young children |
| Macrolide (e.g., azithromycin) | Second-line alternative | Rising pneumococcal resistance reduces reliability |
| Intranasal corticosteroid | Adjunct to reduce mucosal swelling | Modest benefit, low risk |
| Saline irrigation | Supportive care | Low risk, modest symptom relief |
Two versions of the same drug sit at the top for a reason. Clavulanate blocks the beta-lactamase enzymes that inactivate plain amoxicillin, which is the single biggest reason switching to the combination helps in resistant or previously treated cases.
Cost matters less than it once did. Generic amoxicillin is among the cheapest antibiotics available, typically under USD 30 for a full course in the United States without insurance, though cash prices vary by pharmacy and region. Cost is rarely the deciding factor; indication is.
Practical Steps Before and After Filling a Prescription
Track symptoms on a calendar rather than by feel. Note the start date, peak day, and whether day 10 brings improvement. That timeline, not mucus color, drives the decision.
Use supportive care first. Saline irrigation twice daily, intranasal corticosteroids for 10 to 14 days, adequate hydration, and pain relief address the inflammatory component. Sleep with the head elevated to promote drainage.
Ask about diagnostic criteria, not just a prescription. If symptoms began fewer than 10 days ago and are not severe, the appropriate question is whether watchful waiting fits your risk profile.
If antibiotics are prescribed, report allergy history accurately and ask whether a penicillin allergy label can be evaluated. A verified allergy changes the drug choice; an unverified one often does not need to.
Set an expectation of 48 to 72 hours to improvement. Contact the clinician if symptoms worsen or fail to improve by day 3, and return promptly for any red-flag feature.
What Amoxicillin Cannot Fix
Amoxicillin shortens bacterial sinusitis at the margins. Trials show modest benefit over placebo, with cure rates improving by roughly 10 to 15 percentage points, and much of that advantage depends on correct diagnosis. It does not treat viral illness, allergic disease, structural blockage, or chronic inflammatory sinusitis.
Resistance is the long-term cost. Streptococcus pneumoniae resistance to penicillin varies widely by region, and unnecessary prescribing accelerates it. Every course that treats a virus is a course that selects for harder-to-treat bacteria in the population.
The honest bottom line: amoxicillin works for the bacterial minority of sinus infections when the clinical pattern fits. It does not work for the majority, and the discipline is telling the two apart using time, severity, and pattern rather than discharge color or impatience.